Porphyrins as contrast media
暂无分享,去创建一个
[1] D. Rubin,et al. Detection of hepatic malignancies using Mn-DPDP (manganese dipyridoxal diphosphate) hepatobiliary MRI contrast agent. , 1990, Magnetic resonance imaging.
[2] D. Kessel,et al. Porphyrin localization: a new modality for detection and therapy of tumors. , 1984, Biochemical pharmacology.
[3] Y. Kubo,et al. Whole‐body Autoradiography of Tumor‐bearing Hamsters with a New Tumor Imaging Agent, Indium‐111‐labeled Porphyrin , 1988, Japanese journal of cancer research : Gann.
[4] S. Srivastava,et al. Preparation of 109Pd-hematoporphyrin for selective lymphatic ablation using N-methylhematoporphyrin. , 1981, The International journal of applied radiation and isotopes.
[5] U. Nseyo,et al. Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional-cell carcinoma of the bladder. , 1987, The New England journal of medicine.
[6] D Revel,et al. Metalloporphyrin contrast enhancement of tumors in magnetic resonance imaging. A study of human carcinoma, lymphoma, and fibrosarcoma in mice. , 1987, Investigative radiology.
[7] U Schmiedl,et al. Metalloporphyrins as tumor-seeking MRI contrast media and as potential selective treatment sensitizers. , 1990, Investigative radiology.
[8] A Pfefferbaum,et al. Hepatobiliary MR imaging: first human experience with MnDPDP. , 1991, Radiology.
[9] Z. Svitra,et al. Preparation and characterization of copper-67 porphyrin-antibody conjugates. , 1987, Journal of immunological methods.
[10] M. Maines. Zinc . protoporphyrin is a selective inhibitor of heme oxygenase activity in the neonatal rat. , 1981, Biochimica et biophysica acta.
[11] F. Figge,et al. Cancer Detection and Therapy. Affinity of Neoplastic, Embryonic, and Traumatized Tissues for Porphyrins and Metalloporphyrins.∗ , 1948, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[12] J. S. Cohen,et al. Paramagnetic metalloporphyrins as potential contrast agents in NMR imaging , 1984, FEBS letters.
[13] D. Lavallee,et al. The synthesis and characterization of 111In hematoporphyrin derivative. , 1986, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.
[14] P. Alderson,et al. Mn (III) hematoporphyrin. A potential MR contrast agent. , 1990, Investigative radiology.
[15] E. Hahn,et al. Effect of chemotherapy and-or head irradiation on survival of mice with intracranial glioma. , 1971, Radiology.
[16] M. Bronskill,et al. Proton relaxation enhancement by manganese(III)TPPS4 in a model tumor system. , 1987, Magnetic resonance imaging.
[17] J. A. Nelson,et al. Manganese protoporphyrin IX. A potential intravenous paramagnetic NMR contrast agent: preliminary communication. , 1985, Investigative radiology.
[18] J. Lo,et al. Labeling of hematoporphyrin with 105Rh and binding studies with human gamma globulin. , 1990, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.
[19] H. S. Winchell,et al. Potential use of 109Pd-porphyrin complexes for selective lymphatic ablation. , 1971, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[20] M L Yarmush,et al. Antibody-targeted photolysis: selective photodestruction of human T-cell leukemia cells using monoclonal antibody-chlorin e6 conjugates. , 1986, Proceedings of the National Academy of Sciences of the United States of America.